BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 38332564)

  • 1. Blue light aminolevulinic acid photodynamic therapy downregulates cell division and proliferation pathways in cutaneous squamous cell carcinoma.
    Austin E; Mineroff J; Dana I; Jagdeo J
    J Biophotonics; 2024 May; 17(5):e202300369. PubMed ID: 38332564
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of C-X-C motif chemokine ligand 13 in cutaneous squamous cell carcinoma treated with aminolevulinic acid-photodynamic therapy.
    Zhu L; Zhang G; Wang P; Zhang L; Ji J; Liu X; Zhou Z; Zhao J; Wang X
    Photodiagnosis Photodyn Ther; 2019 Jun; 26():389-394. PubMed ID: 31022580
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of ultra short sub-30 minute incubation of 5-aminolevulinic acid photodynamic therapy in vitro.
    Koo E; Austin E; Mamalis A; Jagdeo J
    Lasers Surg Med; 2017 Aug; 49(6):592-598. PubMed ID: 28370019
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acitretin enhances the cytotoxic effect of 5-aminolevulinic acid photodynamic therapy on squamous cell carcinoma cells.
    Ye T; Li D; Yang L; Liu X; Jiang B; Chen B; Zou Y; Yu B
    Photodiagnosis Photodyn Ther; 2022 Sep; 39():102969. PubMed ID: 35714900
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic effect of Imiquimod enhanced ALA-PDT on cutaneous squamous cell carcinoma.
    Bhatta AK; Wang P; Keyal U; Zhao Z; Ji J; Zhu L; Wang X; Zhang G
    Photodiagnosis Photodyn Ther; 2018 Sep; 23():273-280. PubMed ID: 30030167
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of MAPK signaling pathways enhances cell death induced by 5-Aminolevulinic acid-photodynamic therapy in skin squamous carcinoma cells.
    Ge X; Liu J; Shi Z; Jing L; Yu N; Zhang X; Jiao Y; Wang Y; Li PA
    Eur J Dermatol; 2016 Apr; 26(2):164-72. PubMed ID: 27032574
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modified 5-aminolevulinic acid photodynamic therapy reduces pain and improves therapeutic effects in cutaneous squamous cell carcinoma mouse model.
    Zeng Q; Zhou C; Zhang Y; Yan G; Wang X
    Lasers Surg Med; 2022 Jul; 54(5):804-812. PubMed ID: 35066886
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 5-aminolevulinic acid photodynamic therapy inhibits invasion and metastasis of SCL-1 cells probably via MTSS1 and p63 gene related pathways.
    Ye T; Chen T; Jiang B; Yang L; Liu X; Chen B; Zou Y; Yu B
    Photodiagnosis Photodyn Ther; 2020 Dec; 32():102039. PubMed ID: 33017656
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular characterization of gene expression changes in murine cutaneous squamous cell carcinoma after 5-aminolevulinic acid photodynamic therapy.
    Fang S; Wu Y; Zhang H; Zeng Q; Wang P; Zhang L; Yan G; Zhang G; Wang X
    Photodiagnosis Photodyn Ther; 2022 Sep; 39():102907. PubMed ID: 35569747
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Using Fourier transform infrared spectroscopy to evaluate biological effects induced by photodynamic therapy.
    Lima CA; Goulart VP; Correa L; Zezell DM
    Lasers Surg Med; 2016 Jul; 48(5):538-45. PubMed ID: 26899946
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Halofuginone enhances the anti-tumor effect of ALA-PDT by suppressing NRF2 signaling in cSCC.
    Lv T; Huang J; Wu M; Wang H; Zeng Q; Wang X
    Photodiagnosis Photodyn Ther; 2022 Mar; 37():102572. PubMed ID: 34628069
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ALA-PDT successfully treated multiple cSCC in situ and AK in a patient with Epidermodysplasia verruciformis.
    Zhao Z; Wu Y; Zhou Z; Zhao Y; Sun X; Hu C; Wang X; Zhang G
    Photodiagnosis Photodyn Ther; 2021 Sep; 35():102395. PubMed ID: 34126243
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CCL8 enhances sensitivity of cutaneous squamous cell carcinoma to photodynamic therapy by recruiting M1 macrophages.
    Ji J; Wang P; Zhou Q; Zhu L; Zhang H; Zhang Y; Zheng Z; Bhatta AK; Zhang G; Wang X
    Photodiagnosis Photodyn Ther; 2019 Jun; 26():235-243. PubMed ID: 30902794
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparison of invasive squamous cell carcinoma greater than 1 year after treatment with 5-fluorouracil, imiquimod, or photodynamic therapy with aminolevulinic acid.
    Cheng B; Veerabagu S; Miller CJ; Sobanko JF; Shin TM; Higgins HW; Giordano CN; Etzkorn JR
    J Am Acad Dermatol; 2022 Sep; 87(3):592-596. PubMed ID: 35661760
    [TBL] [Abstract][Full Text] [Related]  

  • 15. lncRNA TINCR participates in ALA-PDT-induced apoptosis and autophagy in cutaneous squamous cell carcinoma.
    Zhou W; Zhang S; Li J; Li Z; Wang Y; Li X
    J Cell Biochem; 2019 Aug; 120(8):13893-13902. PubMed ID: 30993776
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification and pharmacological modification of resistance mechanisms to protoporphyrin-mediated photodynamic therapy in human cutaneous squamous cell carcinoma cell lines.
    Schary N; Novak B; Kämper L; Yousf A; Lübbert H
    Photodiagnosis Photodyn Ther; 2022 Sep; 39():103004. PubMed ID: 35811052
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of ALA-PDT on reversing the activation of cancer-associated fibroblasts in cutaneous squamous cell carcinoma.
    Li S; Wang P; Zhang G; Ji J; Lv T; Wang X; Wang H
    Photodiagnosis Photodyn Ther; 2019 Sep; 27():234-240. PubMed ID: 31163284
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A multicenter, randomized, vehicle-controlled phase 2 study of blue light photodynamic therapy with aminolevulinic acid HCl 20% topical solution for the treatment of actinic keratoses on the upper extremities: the effect of occlusion during the drug incubation period.
    Schmieder GJ; Huang EY; Jarratt M
    J Drugs Dermatol; 2012 Dec; 11(12):1483-9. PubMed ID: 23377520
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modified 5-aminolevulinic acid photodynamic therapy (M-PDT) inhibits cutaneous squamous cell carcinoma cell proliferation via targeting PP2A/PP5-mediated MAPK signaling pathway.
    Liu J; Yan G; Chen Q; Zeng Q; Wang X
    Int J Biochem Cell Biol; 2021 Aug; 137():106036. PubMed ID: 34217813
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Photodynamic therapy using aminolaevulinic acid for patients with nonhyperkeratotic actinic keratoses of the face and scalp: phase IV multicentre clinical trial with 12-month follow up.
    Tschen EH; Wong DS; Pariser DM; Dunlap FE; Houlihan A; Ferdon MB;
    Br J Dermatol; 2006 Dec; 155(6):1262-9. PubMed ID: 17107399
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.